Hepatitis C (HCV) is the leading cause for liver transplantation and liver cancer in the United States.

A further increase in Hepatitis C induced liver failure and cancer over the next 10-15 years is predicted without diagnosis and treatment. Treatment can reduce these risks.

However, it is estimated that 78% of patients with Hepatitis C are not diagnosed.

The Comprehensive Liver Center at Hartford Hospital is providing recently FDA-approved treatments that have a cure rate of up to 80% for all genotypes of Hepatitis C, including excellent results for patients with non response to previous available therapies.

We strongly recommend screening all patients with potential risk factors for Hepatitis C and would appreciate the opportunity to participate in the care of any Hepatitis C patient.

Persons for whom HCV screening is recommended:
  • All those born from 1945 - 1965 (Baby Boomers)
  • Persons who have injected illicit drugs in the recent and remote past, including those who injected only once and do not consider themselves to be drug users
  • Persons with conditions associated with a high prevalence of HCV infection including:
    • Persons with HIV infection
    • Persons with hemophilia who received clotting factor concentrates prior to 1987
    • Persons who have ever been on hemodialysis
    • Persons with unexplained abnormal aminotransferase levels
  • Prior recipients of transfusions or organ transplants prior to July 1992 including:
    • • Persons who were notified that they had received blood from a donor who later tested positive for HCV infection
    • • Persons who received a transfusion of blood or blood products
    • • Persons who received an organ transplant
  • Children born to HCV-infected mothers
  • Health care, emergency medical and public safety workers after a needle stick injury or mucosal exposure to HCV-positive blood
  • Current sexual partners of HCV-infected persons AASLD GUIDELINES HEPATOLOGY, Vol. 49, No. 4, 2009
The Comprehensive Liver Center at Hartford Hospital is dedicated to the specialized assessment, treatment and management of patients with liver disease and liver cancer. The infrastructure of the Center allows for patients to be evaluated in a multidisciplinary setting within the same day as visits with a team of providers representing multiple specialties are coordinated from one central location. The Multidisciplinary Care Team is represented by physicians who stay apprised of the most current advances in liver therapy and work together to provide streamlined, coordinated care in close collaboration with referring physicians.